Our processes already enable far too many drugs to enter the market without sufficient assessment. It assessment cycle time is the issue, upgrade the FDA to reduce it. Otherwise this is simply a means for drug companies to realize a return on investment faster. Conversely, there are medicines available overseas that are superior to our's. Why? I've found those countries to be just as conscientious as us.